Collectively, these findings suggest that our observations indicating that KO of ITGα5 in EVP reduces IM IL-6 levels and subsequently diminishes vascular permeability and the establishment of metastatic lesions, may have common implications in other diseases such as COVID-19. The gene discussed is IL6; the disease is COVID-19.